THE MRI FINDINGS OF IRIS METASTASIS IN PATIENTS WITH BREAST CANCER
We report a case of a 51-year-old. She was diagnosed breast cancer two years ago. She was postmenopausal. Histological type was invasive ductal carcinoma and tumor was T2N2M0 and grade III. While estrogen and progesterone receptor status were negative , CerbB2 receptor status was (+++). After surgery ( right modified radical mastectomy and auxiliary dissection) she has received adjuvant chemotherapy (TAC X 6) and trastuzumab for 52 weeks. After 18 months she was admitted to hospital with the complaints of headache on February 2012. On examination there was anisochoria. The magnetic resonance imaging (MRI) revealed multiple brain metastasis. Also the bone sintigraphy revealed multiple bone metastasis. Whole brain radiotherapy was applied to the patients and then palliative chemotherapy (capeticabine + lapatinib) was given. During this period, she was admitted to the hospital with the complaints of lesion on left eye. On ophthalmological examination, there was a solid lesion on iris. The orbital MRI was performed and it revealed the thickness on iris of left eye (Figure (precontrast imaging) and Figure (postcontrast imaging)). Then diagnostic procedure was performed and iris metastasis was diagnosed by fine niddle aspiration biopsy. Final pathological rewiev reported that invasive ductal carcinom metastasis.